6.07
price down icon2.25%   -0.14
after-market 시간 외 거래: 6.07
loading
전일 마감가:
$6.21
열려 있는:
$6.18
하루 거래량:
3.29M
Relative Volume:
0.83
시가총액:
$1.87B
수익:
$493.67M
순이익/손실:
$-104.69M
주가수익비율:
-17.85
EPS:
-0.34
순현금흐름:
$-31.51M
1주 성능:
-2.41%
1개월 성능:
-19.28%
6개월 성능:
-39.18%
1년 성능:
-38.56%
1일 변동 폭
Value
$6.03
$6.195
1주일 범위
Value
$6.03
$6.38
52주 변동 폭
Value
$5.81
$12.65

아미쿠스 테라 Stock (FOLD) Company Profile

Name
명칭
Amicus Therapeutics Inc
Name
전화
(609) 662-2000
Name
주소
47 HULFISH STREET, PRINCETON, NJ
Name
직원
499
Name
트위터
@amicusrx1
Name
다음 수익 날짜
2024-11-06
Name
최신 SEC 제출 서류
Name
FOLD's Discussions on Twitter

FOLD을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
FOLD
Amicus Therapeutics Inc
6.07 1.92B 493.67M -104.69M -31.51M -0.34
Biotechnology icon
ONC
Beone Medicines Ltd Adr
245.58 26.10B 3.81B -644.79M -669.77M -6.24
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
442.05 111.96B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
AKTX
Akari Therapeutics Plc Adr
1.35 42.96M 0 0 0 0.00
Biotechnology icon
VRNA
Verona Pharma Plc Adr
81.20 6.39B 0 -153.72M -103.81M -2.00
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
490.28 63.52B 14.09B 4.50B 2.96B 39.28

아미쿠스 테라 Stock (FOLD) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2024-12-13 다운그레이드 Morgan Stanley Overweight → Equal-Weight
2024-09-06 개시 Jefferies Buy
2024-05-30 개시 Wells Fargo Overweight
2024-05-14 업그레이드 Guggenheim Neutral → Buy
2023-12-19 업그레이드 Morgan Stanley Equal-Weight → Overweight
2022-09-09 개시 Morgan Stanley Equal-Weight
2022-04-13 재개 Goldman Neutral
2022-01-14 업그레이드 SVB Leerink Mkt Perform → Outperform
2021-11-15 업그레이드 Stifel Hold → Buy
2021-09-30 업그레이드 JP Morgan Neutral → Overweight
2021-07-19 재개 BTIG Research Buy
2021-05-27 개시 Needham Hold
2021-05-21 개시 UBS Buy
2021-04-14 업그레이드 Cantor Fitzgerald Neutral → Overweight
2021-03-02 개시 Stifel Hold
2021-02-12 다운그레이드 Cantor Fitzgerald Overweight → Neutral
2021-02-12 다운그레이드 JP Morgan Overweight → Neutral
2020-12-28 재개 Cantor Fitzgerald Overweight
2020-12-10 다운그레이드 Citigroup Buy → Neutral
2020-11-11 개시 Berenberg Hold
2020-06-17 개시 BTIG Research Buy
2020-02-04 재개 Cantor Fitzgerald Overweight
2019-11-12 재확인 H.C. Wainwright Buy
2019-06-17 개시 H.C. Wainwright Buy
2019-06-05 재확인 Cantor Fitzgerald Overweight
2019-04-05 개시 Janney Buy
2019-01-30 개시 Cantor Fitzgerald Overweight
2018-10-29 개시 Citigroup Neutral
2018-08-17 다운그레이드 Chardan Capital Markets Buy → Neutral
2017-10-06 재개 Goldman Neutral
2017-09-13 재확인 Chardan Capital Markets Buy
2017-08-10 재확인 Chardan Capital Markets Buy
2017-01-24 업그레이드 Robert W. Baird Neutral → Outperform
2016-05-18 개시 BofA/Merrill Buy
2016-04-14 개시 Robert W. Baird Neutral
2016-04-12 재확인 Chardan Capital Markets Buy
2015-09-16 다운그레이드 Chardan Capital Markets Buy → Neutral
2015-06-16 재확인 Chardan Capital Markets Buy
모두보기

아미쿠스 테라 주식(FOLD)의 최신 뉴스

pulisher
07:59 AM

Millennium Management LLC Has $4.31 Million Holdings in Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat

07:59 AM
pulisher
03:25 AM

Man Group plc Decreases Stake in Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat

03:25 AM
pulisher
May 30, 2025

Amicus Therapeutics to Present at Upcoming Investor Conferences in June 2025 | FOLD Stock News - GuruFocus

May 30, 2025
pulisher
May 30, 2025

Amicus Therapeutics to Present at Upcoming Investor Conferences in June 2025 - GlobeNewswire

May 30, 2025
pulisher
May 30, 2025

Rare Disease Leader Amicus Therapeutics to Present Latest Updates at Major Healthcare Conferences - Stock Titan

May 30, 2025
pulisher
May 30, 2025

Amicus Therapeutics, Inc. (NASDAQ:FOLD) Shares Sold by Voloridge Investment Management LLC - MarketBeat

May 30, 2025
pulisher
May 28, 2025

Squarepoint Ops LLC Purchases 753,060 Shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat

May 28, 2025
pulisher
May 28, 2025

Neo Ivy Capital Management Increases Stock Position in Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat

May 28, 2025
pulisher
May 28, 2025

Woodline Partners LP Sells 726,952 Shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat

May 28, 2025
pulisher
May 27, 2025

Amicus Therapeutics, Inc. (NASDAQ:FOLD) Shares Purchased by Ameriprise Financial Inc. - Defense World

May 27, 2025
pulisher
May 26, 2025

Pompe Disease Market: Epidemiology, Therapies, Companies, - openPR.com

May 26, 2025
pulisher
May 26, 2025

Teza Capital Management LLC Sells 68,066 Shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat

May 26, 2025
pulisher
May 26, 2025

Nuveen Asset Management LLC Purchases 159,139 Shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat

May 26, 2025
pulisher
May 25, 2025

Amicus Therapeutics, Inc. (NASDAQ:FOLD) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat

May 25, 2025
pulisher
May 25, 2025

297,830 Shares in Amicus Therapeutics, Inc. (NASDAQ:FOLD) Bought by Sovereign s Capital Management LLC - MarketBeat

May 25, 2025
pulisher
May 24, 2025

Vestal Point Capital LP Acquires New Holdings in Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat

May 24, 2025
pulisher
May 23, 2025

Deutsche Bank AG Grows Position in Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat

May 23, 2025
pulisher
May 21, 2025

Rafferty Asset Management LLC Sells 73,883 Shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat

May 21, 2025
pulisher
May 21, 2025

Enzyme Replacement Therapy Market Set to Witness Significant - openPR.com

May 21, 2025
pulisher
May 20, 2025

Janus Henderson Group PLC Cuts Stock Position in Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat

May 20, 2025
pulisher
May 20, 2025

Fabry Disease Market: Epidemiology, Therapies, Companies, - openPR.com

May 20, 2025
pulisher
May 20, 2025

Prosight Management LP Buys Shares of 920,000 Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat

May 20, 2025
pulisher
May 20, 2025

Amicus Therapeutics, Inc. (NASDAQ:FOLD) Given Average Recommendation of “Moderate Buy” by Analysts - Defense World

May 20, 2025
pulisher
May 19, 2025

Amicus Therapeutics, Inc. (NASDAQ:FOLD) Shares Acquired by D. E. Shaw & Co. Inc. - MarketBeat

May 19, 2025
pulisher
May 19, 2025

Enzyme Replacement Therapy Market Generated Opportunities, - openPR.com

May 19, 2025
pulisher
May 19, 2025

Amicus Therapeutics, Inc. (NASDAQ:FOLD) Holdings Cut by BNP Paribas Financial Markets - MarketBeat

May 19, 2025
pulisher
May 18, 2025

Orbimed Advisors LLC Increases Position in Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat

May 18, 2025
pulisher
May 16, 2025

Northern Trust Corp Has $31.76 Million Stock Holdings in Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat

May 16, 2025
pulisher
May 16, 2025

Hudson Bay Capital Management LP Buys 379,800 Shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat

May 16, 2025
pulisher
May 16, 2025

Batten Disease Treatment Market Size, Outlook 2031 by Key - openPR.com

May 16, 2025
pulisher
May 16, 2025

Parkman Healthcare Partners LLC Has $7.39 Million Stock Position in Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat

May 16, 2025
pulisher
May 15, 2025

Balyasny Asset Management L.P. Lowers Stock Holdings in Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat

May 15, 2025
pulisher
May 14, 2025

Raymond James Financial Inc. Purchases Shares of 13,983 Amicus Therapeutics, Inc. (NASDAQ:FOLD) - Defense World

May 14, 2025
pulisher
May 13, 2025

Is Amicus Therapeutics (FOLD) the Best Low Priced Biotech Stock to Buy Now? - Insider Monkey

May 13, 2025
pulisher
May 12, 2025

Bayesian Capital Management LP Purchases 54,100 Shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat

May 12, 2025
pulisher
May 12, 2025

10 Best Low-Priced Biotech Stocks to Buy Now - Insider Monkey

May 12, 2025
pulisher
May 12, 2025

Long Term Trading Analysis for (FOLD) - news.stocktradersdaily.com

May 12, 2025

아미쿠스 테라 (FOLD) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$1.08
price up icon 1.89%
$30.14
price down icon 3.74%
$573.26
price down icon 1.32%
$304.56
price up icon 3.98%
$4.50
price down icon 3.02%
$490.28
price down icon 19.01%
자본화:     |  볼륨(24시간):